| Related Articles |
Pharmaceutical Approval Update.
P T. 2018 Jul;43(7):394-395
Authors: Choy M
Abstract
Fostamatinib (Tavalisse) for thrombocytopenia in adults with chronic immune thrombocytopenia; coagulation factor Xa (recombinant), inactivated-zhzo (Andexxa) for the reversal of anticoagulation; epoetin alfa-epbx (Retacrit), a biosimilar for the treatment of anemia.
PMID: 30013295 [PubMed]